INCR

Intercure Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic

$99.94 sample

+0.91 (+0.92%) 1D

Market cap

$396.5B

Price as of

2026-10-15

Latest filing

8-K

Alerts

8

Price$99.94 +11.55% 3M daily closessample

100.6388.05

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 06INSInsider sell: Director
Sep 28INSInsider sell: 10% owner
Sep 22INSInsider buy: 10% owner
Sep 14INSInsider buy: General Counsel
Sep 08INSInsider sell: Chief Executive Officer
Sep 01INSInsider sell: Director
Aug 27INSInsider sell: 10% owner
Aug 21INSInsider sell: Chief Executive Officer

Sign up to see the real INCR record →

Company facts

SEC EDGAR registration

Name: Intercure Ltd.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Smart-money score: +35sample, -100 to +100
Reporting currency: USD

Who is positioning in INCR

sample

Insiders: 12 insider transactions over 90 days, net selling, $353.6M
Congress: No member trades over 90 days
Institutions · 13F: 40 funds hold $4.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$9.9B +21.4% y/y

Q4 2024Q3 2026

Inventory$5.6B +5.5% y/y

Q4 2024Q3 2026

Accounts receivable$4.3B +7.3% y/y

Q4 2024Q3 2026

Total debt$11.3B +5.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $305.7B -2.2% 3M
Sample peer B: $260.6B -11.2% 3M
Sample peer C: $61.5B -12.8% 3M
Sample peer D: $157.1B +15.9% 3M
Sample peer E: $94.7B -2.8% 3M